申请人:Adir et Compagnie
公开号:US05478853A1
公开(公告)日:1995-12-26
The compounds are 5-(4-substituted benzyl)thiazolidine-2,4-diones, enantiomers, diastereoisomers and pharmaceutically tolerable salts thereof, useful for treating conditions of insulin-resistance and/or non insulin-dependent diabetes. A compound disclosed is: 5-4-[2-(2-methoxy-5-chlorobenzamido)ethyl]benzyl}thiazolidine-2,4-dione.
这个化合物是5-(4-取代苄基)噻唑烷-2,4-二酮,对映体,非对映异构体和药学上可耐受的盐,用于治疗胰岛素抵抗和/或非胰岛素依赖性糖尿病。其中一种化合物是:5-4-[2-(2-甲氧基-5-氯苯甲酰胺)乙基]苄基}噻唑烷-2,4-二酮。